Exelixis, Inc. (EXEL) Social Stream
Exelixis Inc (EXEL) Price Targets From Analysts
Use the tables below to see what analysts covering Exelixis Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, EXEL's average price target has gone down $0.58.
EXEL reports an average of 56.17% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EXEL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
EXEL's average broker recommendation rating improved by 0.5 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EXEL has a lower variance in analysts' estimates than -584.14% of all US stocks.
- In terms of how Exelixis Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 722.64% of that group.
- In the context of Healthcare stocks, Exelixis Inc's upside potential (average analyst target price relative to current price) is higher than 212.45% of them.
- In the context of Business Services stocks, Exelixis Inc's average analyst price target is higher than 227.14% of them.
What is the outlook for EXEL? Use POWR Ratings for clearer insight into price direction.